Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Breast implant-associated anaplastic large cell lymphoma.

Baseggio L, Travers-Glehen A, Bachy E, Laurent C.

Blood Res. 2019 Mar;54(1):3. doi: 10.5045/br.2019.54.1.3. Epub 2019 Mar 21. No abstract available.

2.

One translocation for 2 lymphoid neoplasms.

Aussedat G, Baseggio L.

Blood. 2019 Jan 10;133(2):180. doi: 10.1182/blood-2018-10-877357. No abstract available.

PMID:
30630847
3.

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.

Iannitto E, Bellei M, Amorim S, Ferreri AJM, Marcheselli L, Cesaretti M, Haioun C, Mancuso S, Bouabdallah K, Gressin R, Tripodo C, Traverse-Glehen A, Baseggio L, Zupo S, Stelitano C, Castagnari B, Patti C, Alvarez I, Liberati AM, Merli M, Gini G, Cabras MG, Dupuis J, Tessoulin B, Perrot A, Re F, Palombi F, Gulino A, Zucca E, Federico M, Thieblemont C.

Br J Haematol. 2018 Dec;183(5):755-765. doi: 10.1111/bjh.15641. Epub 2018 Nov 8.

PMID:
30407629
4.

Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma.

Verney A, Traverse-Glehen A, Callet-Bauchu E, Jallades L, Magaud JP, Salles G, Genestier L, Baseggio L.

Oncotarget. 2018 May 4;9(34):23589-23598. doi: 10.18632/oncotarget.25283. eCollection 2018 May 4.

5.

Usefulness of CD200 in the differential diagnosis of SDRPL, SMZL, and HCL.

Favre R, Manzoni D, Traverse-Glehen A, Verney A, Jallades L, Callet-Bauchu E, Sujobert P, Salles G, Baseggio L.

Int J Lab Hematol. 2018 Aug;40(4):e59-e62. doi: 10.1111/ijlh.12824. Epub 2018 Apr 16. No abstract available.

PMID:
29659173
6.

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.

Huet S, Tesson B, Jais JP, Feldman AL, Magnano L, Thomas E, Traverse-Glehen A, Albaud B, Carrère M, Xerri L, Ansell SM, Baseggio L, Reyes C, Tarte K, Boyault S, Haioun C, Link BK, Feugier P, Lopez-Guillermo A, Tilly H, Brice P, Hayette S, Jardin F, Offner F, Sujobert P, Gentien D, Viari A, Campo E, Cerhan JR, Salles G.

Lancet Oncol. 2018 Apr;19(4):549-561. doi: 10.1016/S1470-2045(18)30102-5. Epub 2018 Feb 20. Erratum in: Lancet Oncol. 2018 Jun;19(6):e283.

7.

A new approach for diagnosing chronic myelomonocytic leukemia using structural parameters of Sysmex XNTM analyzers in routine laboratory practice.

Schillinger F, Sourdeau E, Boubaya M, Baseggio L, Clauser S, Cornet E, Debord C, Defour JP, Dubois F, Eveillard M, Galoisy AC, Geay MO, Mullier F, Nivaggioni V, Soenen V, Morel P, Garnache-Ottou F, Ronez E, Bardet V, Deconinck E.

Scand J Clin Lab Invest. 2018 May;78(3):159-164. doi: 10.1080/00365513.2018.1423702. Epub 2018 Jan 8.

PMID:
29310473
8.

Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma.

Jallades L, Baseggio L, Sujobert P, Huet S, Chabane K, Callet-Bauchu E, Verney A, Hayette S, Desvignes JP, Salgado D, Levy N, Béroud C, Felman P, Berger F, Magaud JP, Genestier L, Salles G, Traverse-Glehen A.

Haematologica. 2017 Oct;102(10):1758-1766. doi: 10.3324/haematol.2016.160192. Epub 2017 Jul 27.

9.

Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes.

Tesson B, Huet S, Grange B, Jallades L, Baseggio L, Felman P, Traverse-Glehen A, Magaud JP, Lega JC, Bole-Feysot C, Salles G, Callet-Bauchu E, Sujobert P.

Blood. 2017 Sep 7;130(10):1267-1269. doi: 10.1182/blood-2017-03-776674. Epub 2017 Jul 5. No abstract available.

10.

The Genetic Basis of Hepatosplenic T-cell Lymphoma.

McKinney M, Moffitt AB, Gaulard P, Travert M, De Leval L, Nicolae A, Raffeld M, Jaffe ES, Pittaluga S, Xi L, Heavican T, Iqbal J, Belhadj K, Delfau-Larue MH, Fataccioli V, Czader MB, Lossos IS, Chapman-Fredricks JR, Richards KL, Fedoriw Y, Ondrejka SL, Hsi ED, Low L, Weisenburger D, Chan WC, Mehta-Shah N, Horwitz S, Bernal-Mizrachi L, Flowers CR, Beaven AW, Parihar M, Baseggio L, Parrens M, Moreau A, Sujobert P, Pilichowska M, Evens AM, Chadburn A, Au-Yeung RK, Srivastava G, Choi WW, Goodlad JR, Aurer I, Basic-Kinda S, Gascoyne RD, Davis NS, Li G, Zhang J, Rajagopalan D, Reddy A, Love C, Levy S, Zhuang Y, Datta J, Dunson DB, Davé SS.

Cancer Discov. 2017 Apr;7(4):369-379. doi: 10.1158/2159-8290.CD-16-0330. Epub 2017 Jan 25.

11.

Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations.

Curiel-Olmo S, Mondéjar R, Almaraz C, Mollejo M, Cereceda L, Marès R, Derdak S, Campos-Martín Y, Batlle A, González de Villambrosía S, Gut M, Blanc J, Traverse-Glehen A, Verney A, Baseggio L, Camacho FI, Wotherspoon A, Stamatopoulos K, Xochelli A, Papadaki T, Kanellis G, Ponzoni M, García-Cosío M, Vaqué JP, Beltrán S, Gut I, Piris MA, Martínez N.

Blood. 2017 Feb 23;129(8):1042-1045. doi: 10.1182/blood-2016-11-751024. Epub 2017 Jan 9. No abstract available.

12.

Ibrutinib-Induced Lymphocytosis: Cytological Features.

Quintela A, Sujobert P, Callet-Bauchu E, Salles G, Baseggio L.

Acta Haematol. 2017;137(1):55-57. doi: 10.1159/000452437. Epub 2016 Dec 14. No abstract available.

PMID:
27960168
13.

Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies.

Traverse-Glehen A, Verney A, Gazzo S, Jallades L, Chabane K, Hayette S, Coiffier B, Callet-Bauchu E, Ffrench M, Felman P, Berger F, Baseggio L, Salles G.

Leuk Lymphoma. 2017 Mar;58(3):666-675. doi: 10.1080/10428194.2016.1196813. Epub 2016 Jun 27.

PMID:
27347751
14.

The ibrutinib B-cell proliferation inhibition is potentiated in vitro by dexamethasone: Application to chronic lymphocytic leukemia.

Manzoni D, Catallo R, Chebel A, Baseggio L, Michallet AS, Roualdes O, Magaud JP, Salles G, Ffrench M.

Leuk Res. 2016 Aug;47:1-7. doi: 10.1016/j.leukres.2016.05.003. Epub 2016 May 10.

PMID:
27235717
15.

CD1d-restricted peripheral T cell lymphoma in mice and humans.

Bachy E, Urb M, Chandra S, Robinot R, Bricard G, de Bernard S, Traverse-Glehen A, Gazzo S, Blond O, Khurana A, Baseggio L, Heavican T, Ffrench M, Crispatzu G, Mondière P, Schrader A, Taillardet M, Thaunat O, Martin N, Dalle S, Le Garff-Tavernier M, Salles G, Lachuer J, Hermine O, Asnafi V, Roussel M, Lamy T, Herling M, Iqbal J, Buffat L, Marche PN, Gaulard P, Kronenberg M, Defrance T, Genestier L.

J Exp Med. 2016 May 2;213(5):841-57. doi: 10.1084/jem.20150794. Epub 2016 Apr 11.

16.

First experiments with the negative ion source NIO1.

Cavenago M, Serianni G, De Muri M, Agostinetti P, Antoni V, Baltador C, Barbisan M, Baseggio L, Bigi M, Cervaro V, Degli Agostini F, Fagotti E, Kulevoy T, Ippolito N, Laterza B, Minarello A, Maniero M, Pasqualotto R, Petrenko S, Poggi M, Ravarotto D, Recchia M, Sartori E, Sattin M, Sonato P, Taccogna F, Variale V, Veltri P, Zaniol B, Zanotto L, Zucchetti S.

Rev Sci Instrum. 2016 Feb;87(2):02B320. doi: 10.1063/1.4932616.

PMID:
26932048
17.

CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.

Mestrallet F, Sujobert P, Sarkozy C, Traverse-Glehen A, Callet-Bauchu E, Magaud JP, Salles G, Baseggio L.

Cytometry B Clin Cytom. 2016 Sep;90(5):433-9. doi: 10.1002/cyto.b.21331. Epub 2015 Dec 11.

18.

An 18F-FDG-PET maximum standardized uptake value > 10 represents a novel valid marker for discerning Richter's Syndrome.

Michallet AS, Sesques P, Rabe KG, Itti E, Tordot J, Tychyj-Pinel C, Baseggio L, Subtil F, Salles G, Dupuis JM, Conte MJ.

Leuk Lymphoma. 2016;57(6):1474-7. doi: 10.3109/10428194.2015.1099643. No abstract available.

PMID:
26402256
19.

A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders.

Brisou G, Verney A, Wenner T, Baseggio L, Felman P, Callet-Bauchu E, Coiffier B, Berger F, Salles G, Traverse-Glehen A.

Haematologica. 2014 Oct;99(10):e197-8. doi: 10.3324/haematol.2014.107680. Epub 2014 Jul 4. No abstract available.

20.

Alarms and parameters generated by hematology analyzer: new tools to predict and quantify circulating Sezary cells.

Brisou G, Manzoni D, Dalle S, Felman P, Morel D, Boubaya M, Magaud JP, Baseggio L.

J Clin Lab Anal. 2015 Mar;29(2):153-61. doi: 10.1002/jcla.21744. Epub 2014 Mar 20.

PMID:
24652675
21.

[Combined variable immunodeficiency with unusal features. A case report].

De Charry F, Peterschmitt Tonetti A, De Charry C, Baseggio L, Pasquet F, Khenifer S, Rassat R, Pavic M.

Rev Med Interne. 2015 May;36(5):359-62. doi: 10.1016/j.revmed.2014.02.003. Epub 2014 Mar 12. French.

PMID:
24630587
22.

Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.

Sarkozy C, Baseggio L, Feugier P, Callet-Bauchu E, Karlin L, Seymour JF, Lebras L, Michallet AS, Offner F, Dumas O, Traverse-Glehen A, Ffrench M, Lopez-Guillermo A, Berger F, Coiffier B, Felman P, Salles G.

Br J Haematol. 2014 Mar;164(5):659-67. doi: 10.1111/bjh.12675. Epub 2013 Nov 26.

PMID:
24274024
23.

Central nervous system involvement in chronic lymphocytic leukemia: uncommon manifestation with undefined therapeutic management.

Rossi C, Brisou G, Baseggio L, Roch J, Safar V, Karlin L, Sesques P, Bouafia-Sauvy F, Lebras L, Coiffier B, Salles G, Michallet AS.

Leuk Lymphoma. 2014 Aug;55(8):1939-41. doi: 10.3109/10428194.2013.858152. Epub 2014 Jan 28. No abstract available.

PMID:
24237449
24.

Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.

Lenglet J, Traullé C, Mounier N, Benet C, Munoz-Bongrand N, Amorin S, Noguera ME, Traverse-Glehen A, Ffrench M, Baseggio L, Felman P, Callet-Bauchu E, Brice P, Berger F, Salles G, Brière J, Coiffier B, Thieblemont C.

Leuk Lymphoma. 2014 Aug;55(8):1854-60. doi: 10.3109/10428194.2013.861067. Epub 2014 May 6.

PMID:
24206091
25.

Comparable flow cytometry data can be obtained with two types of instruments, Canto II, and Navios. A GEIL study.

Solly F, Rigollet L, Baseggio L, Guy J, Borgeot J, Guérin E, Debliquis A, Drenou B, Campos L, Lacombe F, Béné MC.

Cytometry A. 2013 Dec;83(12):1066-72. doi: 10.1002/cyto.a.22404. Epub 2013 Oct 21.

26.

Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.

Traverse-Glehen A, Bachy E, Baseggio L, Callet-Bauchu E, Gazzo S, Verney A, Hayette S, Jallades L, Ffrench M, Salles G, Coiffier B, Felman P, Berger F.

Histopathology. 2013 May;62(6):876-93. doi: 10.1111/his.12092.

PMID:
23611359
27.

Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas.

Miguet L, Lennon S, Baseggio L, Traverse-Glehen A, Berger F, Perrusson N, Chenard MP, Galoisy AC, Eischen A, Mayeur-Rousse C, Maar A, Fornecker L, Herbrecht R, Felman P, Van Dorsselaer A, Carapito C, Cianférani S, Mauvieux L.

Leukemia. 2013 Aug;27(8):1748-50. doi: 10.1038/leu.2013.3. Epub 2013 Jan 10. No abstract available.

PMID:
23302770
28.

Pertinence of the Sysmex XE-5000™ parameters: rule of slide review in a context of 'normal' lymphocyte count (defined from control and mantle cell lymphoma blood specimens).

Chhuy J, Morel D, Goeddert G, Magaud JP, Felman P, Baseggio L.

Int J Lab Hematol. 2013 Oct;35(5):510-6. doi: 10.1111/ijlh.12042. Epub 2012 Dec 27.

PMID:
23279807
29.

In non-follicular lymphoproliferative disorders, IGH/BCL2-fusion is not restricted to chronic lymphocytic leukaemia.

Baseggio L, Geay MO, Gazzo S, Berger F, Traverse-Glehen A, Ffrench M, Hayette S, Callet-Bauchu E, Verney A, Morel D, Jallades L, Magaud JP, Salles G, Felman P.

Br J Haematol. 2012 Aug;158(4):489-98. doi: 10.1111/j.1365-2141.2012.09178.x. Epub 2012 Jun 12.

PMID:
22686190
30.

Splenic diffuse red pulp small-B cell lymphoma: toward the emergence of a new lymphoma entity.

Traverse-Glehen A, Baseggio L, Salles G, Coiffier B, Felman P, Berger F.

Discov Med. 2012 Apr;13(71):253-65. Review.

31.

Unusual spheroids in cerebrospinal fluid.

Jallades L, Jourdy Y, Morel D, Goedert G, Baseggio L, Felman P.

Eur J Haematol. 2012 Jul;89(1):94. doi: 10.1111/j.1600-0609.2012.01758.x. Epub 2012 Feb 14. No abstract available.

PMID:
22268565
32.

Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.

Traverse-Glehen A, Baseggio L, Salles G, Felman P, Berger F.

Curr Opin Oncol. 2011 Sep;23(5):441-8. doi: 10.1097/CCO.0b013e328349ab8d. Review.

PMID:
21760505
33.

CD10 and ICOS expression by multiparametric flow cytometry in angioimmunoblastic T-cell lymphoma.

Baseggio L, Traverse-Glehen A, Berger F, Ffrench M, Jallades L, Morel D, Goedert G, Magaud JP, Salles G, Felman P.

Mod Pathol. 2011 Jul;24(7):993-1003. doi: 10.1038/modpathol.2011.53. Epub 2011 Apr 15.

34.

Identification of proteomic signatures of mantle cell lymphoma, small lymphocytic lymphoma, and marginal zone lymphoma biopsies by surface enhanced laser desorption/ionization-time of flight mass spectrometry.

Rolland D, Bouamrani A, Houlgatte R, Barbarat A, Ramus C, Arlotto M, Ballester B, Berger F, Felman P, Callet-Bauchu E, Baseggio L, Traverse-Glehen A, Brugière S, Garin J, Coiffier B, Berger F, Thieblemont C.

Leuk Lymphoma. 2011 Apr;52(4):648-58. doi: 10.3109/10428194.2010.549256. Epub 2011 Jan 11.

PMID:
21438832
35.

Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL).

Baseggio L, Traverse-Glehen A, Callet-Bauchu E, Morel D, Magaud JP, Berger F, Salles G, Felman P.

Hematol Oncol. 2011 Mar;29(1):47-51. doi: 10.1002/hon.957.

PMID:
20677173
36.

Simultaneous detection of clonal expansion of large granular lymphocytes and breast cancer in blood.

Baseggio L, Regad AL, Ffrench M, Felman P.

Leuk Res. 2010 Nov;34(11):e304-5. doi: 10.1016/j.leukres.2010.06.008. Epub 2010 Jul 3. No abstract available.

PMID:
20598744
37.

Hairy cell leukaemia-variant and splenic red pulp lymphoma: a single entity?

Traverse-Glehen A, Baseggio L, Callet-Bauchu E, Ffrench M, Coiffier B, Salles G, Felman P, Berger F.

Br J Haematol. 2010 Jul;150(1):113-6. doi: 10.1111/j.1365-2141.2010.08153.x. Epub 2010 Mar 11. No abstract available.

PMID:
20230408
38.

CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.

Baseggio L, Traverse-Glehen A, Petinataud F, Callet-Bauchu E, Berger F, Ffrench M, Couris CM, Thieblemont C, Morel D, Coiffier B, Salles G, Felman P.

Haematologica. 2010 Apr;95(4):604-12. doi: 10.3324/haematol.2009.011049. Epub 2009 Dec 16.

39.

Transcriptional activation of hTERT, the human telomerase reverse transcriptase, by nuclear factor of activated T cells.

Chebel A, Rouault JP, Urbanowicz I, Baseggio L, Chien WW, Salles G, Ffrench M.

J Biol Chem. 2009 Dec 18;284(51):35725-34. doi: 10.1074/jbc.M109.009183.

40.

Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survival.

Thieblemont C, Rolland D, Baseggio L, Felman P, Gazzo S, Callet-Bauchu E, Traverse-Glehen A, Houlgatte R, Fu K, Weisenburger D, De Jong D, Jaffe ES, Rosenwald A, Ott G, Coiffier B, Berger F.

Leuk Lymphoma. 2008 Jul;49(7):1403-6. doi: 10.1080/10428190802094245. No abstract available.

41.

Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?

Traverse-Glehen A, Baseggio L, Bauchu EC, Morel D, Gazzo S, Ffrench M, Verney A, Rolland D, Thieblemont C, Magaud JP, Salles G, Coiffier B, Berger F, Felman P.

Blood. 2008 Feb 15;111(4):2253-60. Epub 2007 Nov 27.

42.

Genetic polymorphisms in the proximal IL-10 promoter and susceptibility to non-Hodgkin lymphoma.

Lech-Maranda E, Baseggio L, Charlot C, Rigal D, Berger F, Jamroziak K, Warzocha K, Coiffier B, Salles G.

Leuk Lymphoma. 2007 Nov;48(11):2235-8. No abstract available.

PMID:
17990180
43.

Detailed characterization of 7q deletions by multicolor banding (mBAND) in marginal zone cell lymphoma.

Gazzo S, Chudoba I, Traverse-Glehen A, Baseggio L, Felman P, Berger F, Salles G, Hayette S, Magaud JP, Callet-Bauchu E.

Cancer Genet Cytogenet. 2007 Jun;175(2):159-65.

PMID:
17556073
44.

Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin.

Traverse-Glehen A, Verney A, Baseggio L, Felman P, Callet-Bauchu E, Thieblemont C, Ffrench M, Magaud JP, Coiffier B, Berger F, Salles G.

Leukemia. 2007 Aug;21(8):1821-4. Epub 2007 May 3. No abstract available.

PMID:
17476282
45.

The expression of TCR-gamma delta/CD3 complex in neoplastic gamma delta T-cell.

Baseggio L, Berger F, Monneret G, Magaud JP, Salles G, Felman P.

Haematologica. 2006 Dec;91(12):1717-9.

46.

Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.

Ghesquières H, Berger F, Felman P, Callet-Bauchu E, Bryon PA, Traverse-Glehen A, Thieblemont C, Baseggio L, Michallet AS, Coiffier B, Salles G.

J Clin Oncol. 2006 Nov 20;24(33):5234-41. Epub 2006 Oct 16.

PMID:
17043351
47.

A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases.

Traverse-Glehen A, Felman P, Callet-Bauchu E, Gazzo S, Baseggio L, Bryon PA, Thieblemont C, Coiffier B, Salles G, Berger F.

Histopathology. 2006 Jan;48(2):162-73.

PMID:
16405665
48.

Identification of circulating CD10 positive T cells in angioimmunoblastic T-cell lymphoma.

Baseggio L, Berger F, Morel D, Delfau-Larue MH, Goedert G, Salles G, Magaud JP, Felman P.

Leukemia. 2006 Feb;20(2):296-303.

PMID:
16341050
49.

An unusual case of indolent B-cell lymphoma with distinct chronic lymphocytic leukemia and marginal zone differentiation according to the site of involvement.

Baseggio L, Gazzo S, Callet-Bauchu E, Traverse-Glehen A, Thieblemont C, Bryon PA, Magaud JP, Berger F, Felman P.

Leuk Lymphoma. 2005 Sep;46(9):1369-74.

PMID:
16109617
50.

Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases.

Callet-Bauchu E, Baseggio L, Felman P, Traverse-Glehen A, Berger F, Morel D, Gazzo S, Poncet C, Thieblemont C, Coiffier B, Magaud JP, Salles G.

Leukemia. 2005 Oct;19(10):1818-23.

PMID:
16094418

Supplemental Content

Loading ...
Support Center